The impact of fungal infections reaffirm the value of research into the ways that fungi infect humans, and how these infections can be detected, identified and treated.
COVID-19 Pandemic Presents Opportunities for Formal Integration of Antimicrobial Stewardship & Infection Prevention Programs
A 2018 paper jointly published by three leading infectious disease organizations (APIC, SHEA, and SIDP) stated that infection prevention and control and antibiotic stewardship programs are inextricably linked.
The Path to a COVID-19 Vaccine: Large-Scale Efficacy Testing Has Begun
The farthest-along candidates are a viral vector vaccine being tested by the University of Oxford and AstraZeneca, a repurposed vaccine, originally developed in the early 1900s for protection against tuberculosis, and a whole-virus vaccine being tested by the state-owned Chinese company Sinopharm.
How Companies Develop Diagnostics to Support Patient Care
Companies and organizations that provide diagnostics serve an important role and must overcome many challenges inherent to developing diagnostic solutions. These areas include research and development, the regulatory environment, production and manufacturing, commercialization, and insurance and reimbursement.
The Value of Diagnostics in Combatting Antimicrobial Resistance – A Public Health Problem
At this year’s World Anti-Microbial Resistance Congress, Dr. Tristan Timbrook delivered a...
Lindsay Denny Discusses the Critical Role of WASH in Preventing Infectious Diseases and Fighting Antimicrobial Resistance
WASH, which stands for water, sanitation, and hygiene, are basic...